Jean‐Pierre Devogelaer

Author

Also Known As

B Avouac, Christian Roux, D.M. Reid, J DEVOGELAER, J Malghem, J P Devogelaer, J. Devogelaer, J. P Devogelaer, J. P. DEVOGELAER, J. P. Devogelaer

274

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

UCLouvain Cliniques Universitaires Saint-Luc Ghent University Hospital de Duve Institute KU Leuven

About

Jean‐Pierre Devogelaer is an author at UCLouvain specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	41	2.8K
2	Health Sciences	7	7	339
3	Engineering	2	2	49
4	Language Studies	1	1	93
5	Public Health	1	1	50

Jean‐Pierre Devogelaer

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer, New England Journal of Medicine	2004	1.3K
Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides Frédéric Houssiau, Jean‐Pierre Devogelaer, Jo Van Damme, Arthritis & Rheumatism	1988	850
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag, The Lancet Bone DiseaseZoledronic AcidBone HealthGlucocorticoid-induced OsteoporosisMedicine	2009	525
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial Kenneth G. Saag, José Zanchetta, Jean‐Pierre Devogelaer, Arthritis & Rheumatism	2009	485
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial Nick Bishop, Silvano Adami, S Faisal Ahmed, The Lancet Bone DiseaseBone HealthOsteopathyDistraction OsteogenesisPediatrics	2013	196
Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity D. Manicourt, Jean‐Pierre Brasseur, Y. Boutsen, Arthritis & Rheumatism	2004	191
Long-Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate David Hosking, Kenneth W. Lyles, Jacques P. Brown, Journal of Bone and Mineral Research	2006	159
Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club Jean‐Pierre Devogelaer, Stefan Goemaere, Steven Boonen, Osteoporosis International Bone DiseaseBone HealthBelgian Bone ClubEvidence-based GuidelinesGlucocorticoid-induced Osteoporosis	2005	148
Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta Jean‐Pierre Devogelaer, Jacques Malghem, B. Maldague, Skeletal Radiology Bone DiseaseBone HealthOsteopathyPediatricsRadiological Manifestations	1987	140
BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial Francis H. Glorieux, Jean‐Pierre Devogelaer, Michaela Durigova, Journal of Bone and Mineral Research	2017	139

Page 1